CPT1A through succinylation regulates the CTCF/LINC01503‒91aa feedback loop to promote gemcitabine resistance in pancreatic ductal adenocarcinoma

吉西他滨 癌症研究 胰腺导管腺癌 下调和上调 转录组 肉碱 体内 化学 生物 体外 医学 胰腺癌 细胞生物学 HEK 293细胞 转染 调节器 生物信息学 转录因子 基因表达调控 信使核糖核酸 转录调控 琥珀酰化 基因敲除 异位表达 胞苷脱氨酶
作者
De-Liang Fang,Siyuan Lu,Zhide Liu,Qiong‐Cong Xu,Yang‐Yinhui Yu,Ying‐Qin Zhu,Mingjian Ma,Jing‐Yuan Ye,Xiaoyu Yin
出处
期刊:Clinical and translational medicine [Springer Science+Business Media]
卷期号:16 (9): e70776-e70776
标识
DOI:10.1002/ctm2.70776
摘要

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is one of the most malignant solid tumors, characterized by strong invasiveness and poor clinical prognosis. Recent studies have revealed that long non-coding RNAs (lncRNAs) can serve as translational templates to produce functional microproteins, which further participate in the regulation of cellular metabolism. OBJECTIVE: To investigate the function and detailed mechanism of the novel protein 1503-91aa encoded by LINC01503 in gemcitabine-resistant PDAC, and explore the possibility of clinical translation. METHODS: The differentially expressed lncRNAs in gemcitabine-resistant PDAC cells with coding potential were screened by whole transcriptome sequencing and coding prediction from database. A series of cellular, molecular and in vivo assays were performed to characterize the novel microprotein 1503-91aa, its upstream transcriptional regulation, and its role in mediating PDAC gemcitabine resistance. A series of molecular assays clarified the interaction between 1503-91aa and carnitine palmitoyl transferase 1A (CPT1A). Finally, the clinical translational potential of the CPT1A inhibitor etomoxir in combination with gemcitabine was validated using our center's gemcitabine-resistant patient-derived xenograft (PDX) model. RESULTS: Here, we revealed that LINC01503 had coding potential in drug-resistant PDAC and encoded a novel 91-amino acid protein, which designated as 1503-91aa. Simultaneously, LINC01503's transcriptional regulation is mediated by CTCF and then 1503-91aa expression levels were significantly upregulated in PDAC. Functionally, 1503-91aa, instead of LINC01503 confers gemcitabine resistance in vitro and in vivo. Mechanistically, 1503-91aa targeted the CPT1A, and up-regulated CPT1A activity through antagonizing the association of malonyl-CoA (MCoA), the best known metabolic intermediate inhibiting CPT1A, to promote fatty acid oxidation (FAO) and thereby facilitate gemcitabine resistance. We discovered that CPT1A functions as a succinyltransferase to regulate the succinylation level of CTCF, thereby controlling its stability. This establishes a positive feedback loop that continuously sustains 1503-91aa protein levels to regulate CPT1A activity. Consequently, this induces persistent FAO in PDAC cells, ensuring a continuous energy source that facilitates gemcitabine resistance in pancreatic cancer. Notably, the combined application of the etomoxir and gemcitabine exerts a synergistic effect on PDAC. CONCLUSIONS: These findings provide novel insights into the molecular mechanisms underlying gemcitabine resistance in PDAC and highlight CTCF/LINC01503-91aa/CPT1A feedback loop as a potential prognostic biomarkers and therapeutic targets. KEY POINTS: We identified that LINC01503 is capable of encoding the protein product 1503-91aa. 1503-91aa competed with MCoA to unleash CPT1A activity for fatty acid oxidation and thereby mediating gemcitabine resistance in PDAC. Etomoxir and gemcitabine have synergistic effects in gemcitabine efficiency.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
是唐朝越啊完成签到,获得积分10
刚刚
LGL发布了新的文献求助10
刚刚
YAYING发布了新的文献求助10
2秒前
鹿饮溪发布了新的文献求助10
2秒前
王乐乐发布了新的文献求助10
3秒前
zhangyi完成签到 ,获得积分10
3秒前
占曼荷完成签到,获得积分20
3秒前
只只完成签到,获得积分10
3秒前
Taikonaut发布了新的文献求助10
3秒前
jiehe完成签到,获得积分10
4秒前
小蘑菇的应助被lqiu采纳,获得10
4秒前
水蜜桃完成签到,获得积分10
4秒前
无花果的应助被飞鸿影下采纳,获得10
5秒前
AXQ完成签到,获得积分10
7秒前
CDabin完成签到,获得积分10
7秒前
Jasper的应助被欣喜若魔采纳,获得20
7秒前
科研通AI6.2的应助被llll采纳,获得10
7秒前
椰妃完成签到,获得积分10
8秒前
传统的冷霜完成签到,获得积分10
9秒前
小西门完成签到,获得积分10
10秒前
研友_Z6Qrbn发布了新的文献求助10
11秒前
Eric的应助被少双采纳,获得10
11秒前
11秒前
李爱国的应助被哈斯u和采纳,获得10
12秒前
鹿饮溪完成签到,获得积分20
14秒前
14秒前
14秒前
汤包发布了新的文献求助10
15秒前
欣喜若魔完成签到,获得积分10
16秒前
17秒前
Jigsaw发布了新的文献求助10
17秒前
17秒前
想吃小面包完成签到 ,获得积分10
18秒前
脆脆炸香蕉完成签到,获得积分10
18秒前
CipherSage的应助被Irene采纳,获得10
18秒前
19秒前
欣喜若魔发布了新的文献求助20
19秒前
19秒前
19秒前
ldkshifo完成签到,获得积分10
20秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Agyptische Geschichte der 21.30. Dynastie 510
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8192078
求助须知:如何正确求助?哪些是违规求助? 9578698
关于积分的说明 21861559
捐赠科研通 7791583
什么是DOI,文献DOI怎么找? 3436814
关于科研通互助平台的介绍 2560538
邀请新用户注册赠送积分活动 2483582